The therapeutic effect of piperacillin sodium and sulbactum sodium(PIP/SBT)for injection in children bronchopneumonia
10.3969/j.issn.1005-1678.2017.07.094
- VernacularTitle:注射用哌拉西林钠他唑巴坦钠治疗小儿支气管肺炎的疗效观察
- Author:
Yudong LIU
;
Hao WANG
;
Yao ZHANG
;
Ling LI
;
Huajie HAO
;
Xin SUN
- Keywords:
piperacillin sodium and sulbactum sodium(PIP/SBT)for injection;
pediatrics;
bronchopneumonia;
therapeutic effect
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(7):235-236,238
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyzed the therapeutic effect of piperacillin sodium and sulbactum sodium(PIP/SBT)for injection in children bronchopneumonia.Methods 162 bronchopneumonia children who were admitted to pediatrics department during January 2014 to January 2016 were enrolled for this study and randomly divided into the observation group and the control group.The observation group received piperacillin sodium and sulbactum sodium therapy, while the control group received azithromycin.The symptom scores of coughing, wheezing, wheezing sound and the difficulty of expectoration in the 3rd day and 7th day were compared.The therapeutic effect of the two groups were evaluated.Results The observation group and the control group could both improve the symptom scores of coughing, wheezing, wheezing sound and the difficulty of expectoration in the 3rd day and 7th day, while the scores of observation group were significantly lower than the control ones.And the effective rate of observation group(97.5%)was significantly higher than the control one(90.1%).Conclusion Piperacillin sodium and sulbactum sodium(PIP/SBT)for injection had significantly clinical effect applying in children bronchopneumonia treatment, which was worthy of further popularization and application.
